Fuji Film HD Starts Joint Phase II Trials With Alzheimer’s Drug
This article was originally published in PharmAsia News
Executive Summary
Fuji Film HD’s group company Toyama Chemicals has begun Phase II trials with the Alzheimer’s drug T-817MA, Fuji Film announced on June 9.